stockmarketnews.online EDGAR snapshot
The Filings Docket Corporate filings, explained: what large U.S. companies filed with the SEC, and what it means.

In re: GILEAD SCIENCES, INC. · CIK 0000882095

When will Gilead Sciences, Inc. file its next 10-Q?

GILD · Nasdaq
Snapshot

Gilead Sciences, Inc. is expected to file its next quarterly report (Form 10-Q), for the period ending about Sept. 30, 2026, between Nov. 6, 2026 and Nov. 9, 2026, based on its last 8 10-Q filings. The SEC deadline for a large accelerated filer is Nov. 9, 2026.

How the next-report window is calculated

Gilead Sciences, Inc.'s most recent periodic report on file is a Form 10-Q for the period ended June 30, 2026, filed Aug. 6, 2026. Its fiscal year ends around Dec. 31, so the next period should close about Sept. 30, 2026, and that report is a Form 10-Q.

SEC rules give a large accelerated filer 40 days after period end to file a 10-Q, which lands on Nov. 9, 2026 after moving off weekends and federal holidays. Over its last 8 10-Qs, Gilead Sciences, Inc. filed between 37 and 43 days after period end (median 38 days), which gives the expected window above. Period ends are estimated from the company's own calendar and may shift by a few days in 52/53-week fiscal years.

Gilead Sciences, Inc.: days from period end to 10-Q/10-K filing 10-Q for period ended 2024-09-30: filed 43 days later; 10-K for period ended 2024-12-31: filed 59 days later; 10-Q for period ended 2025-03-31: filed 37 days later; 10-Q for period ended 2025-06-30: filed 38 days later; 10-Q for period ended 2025-09-30: filed 38 days later; 10-K for period ended 2025-12-31: filed 55 days later; 10-Q for period ended 2026-03-31: filed 37 days later; 10-Q for period ended 2026-06-30: filed 37 days later. 10-Q due: 40d 10-K due: 60d 10-Q · Sept. 30 24 43d 10-K · Dec. 31 24 59d 10-Q · March 31 25 37d 10-Q · June 30 25 38d 10-Q · Sept. 30 25 38d 10-K · Dec. 31 25 55d 10-Q · March 31 26 37d 10-Q · June 30 26 37d days from period end to filing date →

Recent filings by Gilead Sciences, Inc.

Most recent 25 filings excluding insider Forms 3/4/5/144 · SEC EDGAR, retrieved Oct. 16, 2026
FiledFormWhat it isDocument
13D/A Amendment to an active-ownership (13D) report Open SCHEDULE 13D/A filed 2026-08-07 · Index 0001104659-26-092737
S-3ASR Automatic shelf registration (well-known seasoned issuer) Open S-3ASR filed 2026-08-06 · Index 0001104659-26-092110
10-Q Quarterly report with unaudited financial statements for the period ended June 30, 2026 Open 10-Q filed 2026-08-06 · Index 0000882095-26-000031
8-K Released earnings or financial results Open 8-K filed 2026-08-04 · Index 0000882095-26-000028
13D/A Amendment to an active-ownership (13D) report Open SCHEDULE 13D/A filed 2026-05-27 · Index 0001123292-26-000750
8-K Signed a material contract; took on new debt or a similar obligation; other events the company chose to report Open 8-K filed 2026-05-20 · Index 0001104659-26-064518
S-8 Registration of shares for employee benefit plans Open S-8 filed 2026-05-07 · Index 0000882095-26-000025
10-Q Quarterly report with unaudited financial statements for the period ended March 31, 2026 Open 10-Q filed 2026-05-07 · Index 0000882095-26-000024
8-K Released earnings or financial results Open 8-K filed 2026-05-07 · Index 0000882095-26-000022
8-K Reported shareholder vote results Open 8-K filed 2026-05-04 · Index 0000882095-26-000008
13G Ownership above 5% by a passive or institutional investor Open SCHEDULE 13G filed 2026-04-29 · Index 0002100119-26-000510
13D/A Amendment to an active-ownership (13D) report Open SCHEDULE 13D/A filed 2026-04-28 · Index 0001104659-26-049902
8-K Information shared under Regulation FD; other events the company chose to report Open 8-K filed 2026-04-28 · Index 0001104659-26-049874
13G/A Amendment to a passive-ownership (13G) report Open SCHEDULE 13G/A filed 2026-03-26 · Index 0000102909-26-001398
ARS Annual report delivered to shareholders Open ARS filed 2026-03-20 · Index 0001308179-26-000108
DEFA14A Additional proxy soliciting materials Open DEFA14A filed 2026-03-20 · Index 0001308179-26-000107
DEF 14A Definitive proxy statement for a shareholder meeting Open DEF 14A filed 2026-03-20 · Index 0001308179-26-000106
10-K Annual report with audited financial statements for the period ended Dec. 31, 2025 Open 10-K filed 2026-02-24 · Index 0000882095-26-000006
13D Ownership above 5% by an investor who may seek influence Open SCHEDULE 13D filed 2026-02-23 · Index 0000904454-26-000123
8-K Signed a material contract; information shared under Regulation FD Open 8-K filed 2026-02-23 · Index 0001104659-26-018314
13G/A Amendment to a passive-ownership (13G) report Open SCHEDULE 13G/A filed 2026-02-12 · Index 0001123292-26-000166
13G/A Amendment to a passive-ownership (13G) report Open SCHEDULE 13G/A filed 2026-02-12 · Index 0001123292-26-000163
8-K Released earnings or financial results Open 8-K filed 2026-02-10 · Index 0000882095-26-000003
13G Ownership above 5% by a passive or institutional investor Open SCHEDULE 13G filed 2026-02-05 · Index 0000315066-26-000432
8-K Executive or board change, or executive pay arrangement Open 8-K filed 2025-11-19 · Index 0001104659-25-113968

What Gilead Sciences, Inc.'s 8-Ks were about in the past year

Gilead Sciences, Inc. filed 9 Form 8-K current reports between Oct. 17, 2025 and Oct. 16, 2026. Each report lists the item numbers it covers; the counts below show how often each item appeared.

ItemMeaningTimes
9.01Financial Statements and Exhibits8
2.02Results of Operations and Financial Condition4
1.01Entry into a Material Definitive Agreement2
8.01Other Events2
7.01Regulation FD Disclosure2
2.03Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement1
5.07Submission of Matters to a Vote of Security Holders1
5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers1

See what each 8-K item means.